|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 6 (September 15), 1998:
pp. 2084-2092
Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus
Type 1 (HIV-1) Infection: Correlation to Disease Progression and
Clinical Events
Egil Lien,
Pål Aukrust,
Anders Sundan,
Fredrik Müller,
Stig
S. Frøland, and
Terje Espevik
From The Institute of Cancer Research and Molecular Biology,
Norwegian University of Science and Technology, University Medical
Center, Trondheim, Norway; and the Section of Clinical Immunology and
Infectious Diseases, Medical Department A and Research Institute for
Internal Medicine, University of Oslo, The National Hospital, Oslo,
Norway.
Soluble (s) CD14, a marker for monocyte/macrophage activation and a
mediator of bacterial lipopolysaccharide (LPS) action, was elevated in
serum from human immunodeficiency virus type 1 (HIV- 1)-infected
individuals (n = 92) compared with seronegative controls. The highest
levels were found in patients with advanced clinical and immunological
disease. Patients with ongoing clinical events had significantly higher
sCD14 levels than symptomatic HIV-1-infected individuals without
clinical events, with especially elevated levels in patients infected
with Mycobacterium avium complex (MAC). On longitudinal testing
of patients (n = 26) with less than 100 × 106
CD4 lymphocytes/L at baseline, we found that increasing sCD14 serum
concentrations per time unit were associated with death, whereas no
differences in CD4 cell number decrease were found between survivors
and nonsurvivors. In vitro studies showed that HIV-1 glycoprotein 120 and purified protein derivative (PPD) from M avium (MAC-PPD)
stimulated normal monocytes to release sCD14. Furthermore, MAC-PPD
induced tumor necrosis factor (TNF) release from monocytes
through interactions with CD14 and, importantly, the addition of sCD14
enhanced this MAC-PPD stimulatory effect. Our findings suggest that the
CD14 molecule may be involved in the immunopathogenesis of HIV-1
infection, and it is conceivable that serial determination of sCD14 may
give useful predictive information concerning disease progression and
survival in HIV-1-infected patients.
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
W.-K. Kim, X. Alvarez, J. Fisher, B. Bronfin, S. Westmoreland, J. McLaurin, and K. Williams
CD163 Identifies Perivascular Macrophages in Normal and Viral Encephalitic Brains and Potential Precursors to Perivascular Macrophages in Blood
Am. J. Pathol.,
March 1, 2006;
168(3):
822 - 834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Turner, M. Hoffman, I. Yust, M. Fried, M. Bleiberg, and B. Tartakovsky
Overexpression of a Novel Lymphocyte Population, Positive for an Intracellular CD14-Like Antigen, in Patients Positive for Human Immunodeficiency Virus Type 1
Clin. Vaccine Immunol.,
November 1, 2004;
11(6):
1040 - 1044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-F. Fortin, C. Barat, Y. Beausejour, B. Barbeau, and M. J. Tremblay
Hyper-responsiveness to Stimulation of Human Immunodeficiency Virus-infected CD4+ T Cells Requires Nef and Tat Virus Gene Products and Results from Higher NFAT, NF-{kappa}B, and AP-1 Induction
J. Biol. Chem.,
September 17, 2004;
279(38):
39520 - 39531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Guerra, I. C. Lohman, M. Halonen, F. D. Martinez, and A. L. Wright
Reduced Interferon {gamma} Production and Soluble CD14 Levels in Early Life Predict Recurrent Wheezing by 1 Year of Age
Am. J. Respir. Crit. Care Med.,
January 1, 2004;
169(1):
70 - 76.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-K. Kim, S. Corey, X. Alvarez, and K. Williams
Monocyte/macrophage traffic in HIV and SIV encephalitis
J. Leukoc. Biol.,
November 1, 2003;
74(5):
650 - 656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Crowe, T. Zhu, and W. A. Muller
The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection
J. Leukoc. Biol.,
November 1, 2003;
74(5):
635 - 641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Creery, J. B. Angel, S. Aucoin, W. Weiss, W. D. Cameron, F. Diaz-Mitoma, and A. Kumar
Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10
Clin. Vaccine Immunol.,
November 1, 2002;
9(6):
1212 - 1221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. N. Fichorova, A. O. Cronin, E. Lien, D. J. Anderson, and R. R. Ingalls
Response to Neisseria gonorrhoeae by Cervicovaginal Epithelial Cells Occurs in the Absence of Toll-Like Receptor 4-Mediated Signaling
J. Immunol.,
March 1, 2002;
168(5):
2424 - 2432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. LeVan, J. W. Bloom, T. J. Bailey, C. L. Karp, M. Halonen, F. D. Martinez, and D. Vercelli
A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity
J. Immunol.,
November 15, 2001;
167(10):
5838 - 5844.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Lawn, S. T. Butera, and T. M. Folks
Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection
Clin. Microbiol. Rev.,
October 1, 2001;
14(4):
753 - 777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. F. Jorgensen, J. E. Wang, M. Almlof, C. Thiemermann, S. J. Foster, R. Solberg, and A. O. Aasen
Peptidoglycan and Lipoteichoic Acid Modify Monocyte Phenotype in Human Whole Blood
Clin. Vaccine Immunol.,
May 1, 2001;
8(3):
515 - 521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Arias, J. E. Rey Nores, N. Vita, F. Stelter, L. K. Borysiewicz, P. Ferrara, and M. O. Labeta
Cutting Edge: Human B Cell Function Is Regulated by Interaction with Soluble CD14: Opposite Effects on IgG1 and IgE Production
J. Immunol.,
April 1, 2000;
164(7):
3480 - 3486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Lawn, B. D. Roberts, G. E. Griffin, T. M. Folks, and S. T. Butera
Cellular Compartments of Human Immunodeficiency Virus Type 1 Replication In Vivo: Determination by Presence of Virion-Associated Host Proteins and Impact of Opportunistic Infection
J. Virol.,
January 1, 2000;
74(1):
139 - 145.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. Lien, T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, et al.
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products
J. Biol. Chem.,
November 19, 1999;
274(47):
33419 - 33425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Lien, J. C. Chow, L. D. Hawkins, P. D. McGuinness, K. Miyake, T. Espevik, F. Gusovsky, and D. T. Golenbock
A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway
J. Biol. Chem.,
January 12, 2001;
276(3):
1873 - 1880.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
